__NUXT_JSONP__("/drugs/Pixantrone_Dimaleate", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[{activeSubstance:b,conditionIndication:"Pixuvri is indicated as monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas (NHL). The benefit of pixantrone treatment has not been established in patients when used as fifth-line or greater chemotherapy in patients who are refractory to last therapy.",inn:b,marketingAuthorisationDate:"2012-05-10 00:00:00",marketingAuthorisationHolder:"Les Laboratoires Servier",medicineName:"Pixuvri",url:"https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fmedicines\u002Fhuman\u002FEPAR\u002Fpixuvri"}],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"144675-97-8",chebiId:"",chemicalFormula:"C17H19N5O2.2C4H4O4",definition:"The dimaleate salt of a synthetic, noncardiotoxic aza-anthracenedione analogue with potential antineoplastic activity. Pixantrone intercalates into DNA and induces topoisomerase II-mediated DNA strand crosslinks, resulting in inhibition of DNA replication and tumor cell cytotoxicity.",fdaUniiCode:"P0R64C4CR9",identifier:"C82398",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C582"],synonyms:["6,9-Bis((2-Aminoethyl)Amino)Benzo(g)Isoquinoline-5,10-Dione (2z)-But-2-Enedioate (1:2)","BBR 2778","Benz(g)Isoquinoline-5,10-Dione, 6,9-Bis((2-Aminoethyl)Amino)-, (2z)-2-Butenedioate (1:2)","Benz(g)isoquinoline-5,10-dione, 6,9-bis((2-aminoethyl)amino)-, (2Z)-2-butenedioate (1:2)","PIXANTRONE DIMALEATE",c,"Pixantrone Maleate"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FPixantrone_Dimaleate",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Pixantrone_Dimaleate","pixantrone dimaleate","Pixantrone Dimaleate","2021-10-30T13:45:58.603Z")));